Efficacy of Admission Screening for Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Lowe, Christopher F ^a   Katz, Kevin ^a,b   McGeer, Allison J ^a,c   Muller, Matthew P ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b NORTH YORK GENERAL HOSPITAL   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANADA; COHORT ANALYSIS; CONTROLLED STUDY; ENTEROBACTERIACEAE INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HOSPITAL ADMISSION; HOSPITAL ADMISSION SCREENING; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; NONHUMAN; RETROSPECTIVE STUDY; SCREENING TEST;

BETA-LACTAMASES; CANADA; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS; HUMANS; INCIDENCE; MASS SCREENING; PATIENT ADMISSION; RECTUM;

ENTEROBACTERIACEAE;

EID: 84876846960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062678     Document Type: Article

References (20)

1. Infectious Diseases Society of America, Spellberg B, Blaser M, Guidos RJ, Boucher HW, et al (2011) Combating antimicrobial resistance: Policy recommendations to save lives. Clin Infect Dis 52Suppl 5: S397-428.
2. Lowe CF, McGeer A, Muller MP, Katz K, (2012) Toronto ESBL Working Group (2012) Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada. Antimicrob Agents Chemother 56: 3977-3980.
3. Pitout JD, Laupland KB, (2008) Extended-spectrum beta-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet Infect Dis 8: 159-166.
4. Pitout JD, (2010) Infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae: Changing epidemiology and drug treatment choices. Drugs 70: 313-333.
5. Goddard S, Muller MP, (2011) The efficacy of infection control interventions in reducing the incidence of extended-spectrum beta-lactamase-producing Enterobacteriaceae in the nonoutbreak setting: A systematic review. Am J Infect Control 39: 599-601.
6. Gardam MA, Burrows LL, Kus JV, Brunton J, Low DE, et al. (2002) Is surveillance for multidrug-resistant Enterobacteriaceae an effective infection control strategy in the absence of an outbreak? J Infect Dis 186: 1754-1760.
7. Abad C, Fearday A, Safdar N, (2010) Adverse effects of isolation in hospitalised patients: A systematic review. J Hosp Infect 76: 97-102.
8. Lucet JC, Decre D, Fichelle A, Joly-Guillou ML, Pernet M, et al. (1999) Control of a prolonged outbreak of extended-spectrum beta-lactamase-producing Enterobacteriaceae in a university hospital. Clin Infect Dis 29: 1411-1418.
9. Ben-David D, Maor Y, Keller N, Regev-Yochay G, Tal I, et al. (2010) Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection. Infect Control Hosp Epidemiol 31: 620-626.
10. Borer A, Eskira S, Nativ R, Saidel-Odes L, Riesenberg K,et al. A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in southern Israel. Infect Control Hosp Epidemiol 32: 1158-1165.
11. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, et al. (2010) Controlling the spread of carbapenemase-producing gram-negatives: Therapeutic approach and infection control. Clin Microbiol Infect 16: 102-111.
12. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, et al. (2003) SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 24: 362-386.
13. Lowe C, Katz K, McGeer A, Muller MP, (2012) Toronto ESBL Working Group (2012) Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control 40: 836-839.
14. Clinical Laboratory Standards Institute (2009) Performance standards for antimicrobial susceptibilities testing: 19th informational supplement. M100-S19. CLSI, Wayne, PA.
15. Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, et al. (2007) How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 35: 97-101.
16. Harris AD, Perencevich EN, Johnson JK, Paterson DL, Morris JG, et al. (2007) Patient-to-patient transmission is important in extended-spectrum beta-lactamase-producing Klebsiella pneumoniae acquisition. Clin Infect Dis 45: 1347-1350.
17. Weintrob AC, Roediger MP, Barber M, Summers A, Fieberg AM, et al. (2010) Natural history of colonization with gram-negative multidrug-resistant organisms among hospitalized patients. Infect Control Hosp Epidemiol 31: 330-337.
18. Laurent C, Rodriguez-Villalobos H, Rost F, Strale H, Vincent JL, et al. (2008) Intensive care unit outbreak of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae controlled by cohorting patients and reinforcing infection control measures. Infect Control Hosp Epidemiol 29: 517-524.
19. Siegel JD, Rhinehart E, Jackson M, Chiarello L, (2007) Healthcare Infection Control Practices Advisory Committee (2007) Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 35Suppl 2: S165-193.
20. Public Health Agency of Canada (2010) Guidance: Infection prevention and control measures for healthcare workers in all healthcare settings: carbapenem-resistant gram-negative bacilli. Available: http://www.phac-aspc.gc.ca/nois-sinp/guide/ipcm-mpci/pdf/guide-eng.pdf. Accessed 2011 January 10.